Tag: Biomedical Advanced Research and Development Authority

September 21, 2018

Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today announced that it has...
August 16, 2018

Summit Awarded Additional US$12 Million from BARDA

On Thursday, Summit Therapeutics was awarded an additional US$12 million, bringing its total to US$44 million in gross committed funding...
August 16, 2018

Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection

Summit Therapeutics (NASDAQ:SMMT, AIM:SUMM), a leader in antibiotic innovation, today announces that it has been awarded an additional $12 million...